Hello, they are Alexandra Muller in London and Filipe Pacheco in Hong Kong. As noted in Thursday’s newsletter, some people are becoming increasingly optimistic about mergers and acquisitions in Asia. The same cannot be said for the region’s IPOs, as we explain today. Plus, Ken Moelis isn’t going anywhere.
Today’s top stories
From the moment ChemChina announced its $43 billion takeover of Swiss seeds and pesticides company Syngenta in 2016, the buyer was preparing investors for an eventual relisting of the company. Nearly eight years later, the IPO is as far away as ever, boding poorly for new listings in Asia for the rest of the year.
Comments are closed.